1. Home
  2. Analysis
  3. Osteopenia
  4. Application-site-erythema

Osteopenia and Application site erythema

Summary:

Application site erythema is found among people with Osteopenia, especially for people who are female, 60+ old.

The study analyzes which people have Application site erythema with Osteopenia. It is created by eHealthMe based on reports of 16 people who have Osteopenia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Osteopenia?

Osteopenia (a condition where bone mineral density is lower than normal) is found to be associated with 1,434 drugs and 1,172 conditions by eHealthMe. Check the latest studies of Osteopenia.

What is Application site erythema?

Application site erythema (redness of the skin at application site) is found to be associated with 667 drugs and 950 conditions by eHealthMe. Check the latest studies of Application site erythema.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

16 people who have Osteopenia and Application Site Erythema are studied.

Would you have Application site erythema when you have Osteopenia?

Gender of people who have Osteopenia and experienced Application Site Erythema *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Osteopenia and experienced Application Site Erythema *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 10 %
  • 50-59: 40 %
  • 60+: 50 %

Common co-existing conditions for these people *:

  1. High Blood Cholesterol: 5 people, 31.25%
  2. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 4 people, 25.00%
  3. Pain: 4 people, 25.00%
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 25.00%
  5. Sleep Disorder: 3 people, 18.75%
  6. Migraine (headache): 2 people, 12.50%
  7. Menopause (end of monthly cycles in women): 2 people, 12.50%
  8. Constipation: 2 people, 12.50%
  9. Depression: 2 people, 12.50%
  10. Dry Eyes (lack of adequate tears): 2 people, 12.50%

Common drugs taken by these people *:

  1. Oxytrol For Women: 6 people, 37.50%
  2. Vitamin D: 3 people, 18.75%
  3. Synthroid: 3 people, 18.75%
  4. Aspirin: 3 people, 18.75%
  5. Lamictal: 3 people, 18.75%
  6. Evista: 3 people, 18.75%
  7. Omega 3: 2 people, 12.50%
  8. Flector: 2 people, 12.50%
  9. Humira: 2 people, 12.50%
  10. Imitrex: 2 people, 12.50%

Common symptoms for these people *:

  1. Application Site Pruritus (application site severe itching of the skin): 9 people, 56.25%
  2. Application Site Rash: 6 people, 37.50%
  3. Application Site Swelling: 3 people, 18.75%
  4. Rashes (redness): 3 people, 18.75%
  5. High Blood Cholesterol: 3 people, 18.75%
  6. Application Site Pain: 2 people, 12.50%
  7. Skin Discoloration: 2 people, 12.50%
  8. Skin Burning Sensation: 2 people, 12.50%
  9. Discomfort: 2 people, 12.50%
  10. Localised Oedema (fluid retention in a particular part of the body): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Application site erythema?

- Check whether Application site erythema is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Application site erythema:

All the conditions that are associated with Application site erythema:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Application site erythema and Osteopenia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.